Celladon Announces Exercise in Full and Closing of Underwriters' Option to Purchase Additional

SAN DIEGO, Feb 27, 2014 (GLOBE NEWSWIRE via COMTEX) — Celladon Corporation (NASDAQ:CLDN) , a clinical-stage biotechnology company